Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.
2.

Antigen mRNA-transfected, allogeneic fibroblasts loaded with NKT-cell ligand confer antitumor immunity.

Fujii S, Goto A, Shimizu K.

Blood. 2009 Apr 30;113(18):4262-72. doi: 10.1182/blood-2008-08-176446. Epub 2009 Jan 22.

PMID:
19164596
[PubMed - indexed for MEDLINE]
Free Article
3.

Vaccination with antigen-transfected, NKT cell ligand-loaded, human cells elicits robust in situ immune responses by dendritic cells.

Shimizu K, Mizuno T, Shinga J, Asakura M, Kakimi K, Ishii Y, Masuda K, Maeda T, Sugahara H, Sato Y, Matsushita H, Nishida K, Hanada K, Dorrie J, Schaft N, Bickham K, Koike H, Ando T, Nagai R, Fujii S.

Cancer Res. 2013 Jan 1;73(1):62-73. doi: 10.1158/0008-5472.CAN-12-0759. Epub 2012 Oct 29.

PMID:
23108144
[PubMed - indexed for MEDLINE]
Free Article
4.

Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes.

Gehrmann U, Hiltbrunner S, Georgoudaki AM, Karlsson MC, Näslund TI, Gabrielsson S.

Cancer Res. 2013 Jul 1;73(13):3865-76. doi: 10.1158/0008-5472.CAN-12-3918. Epub 2013 May 8.

PMID:
23658368
[PubMed - indexed for MEDLINE]
Free Article
5.

Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice.

Fujii S, Shimizu K, Hemmi H, Fukui M, Bonito AJ, Chen G, Franck RW, Tsuji M, Steinman RM.

Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11252-7. Epub 2006 Jul 14.

PMID:
16844772
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.

Wu L, Gabriel CL, Parekh VV, Van Kaer L.

Tissue Antigens. 2009 Jun;73(6):535-45. doi: 10.1111/j.1399-0039.2009.01256.x. Epub 2009 Apr 8. Review.

PMID:
19392798
[PubMed - indexed for MEDLINE]
7.

Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.

Fujii S, Shimizu K, Hemmi H, Steinman RM.

Immunol Rev. 2007 Dec;220:183-98. Review.

PMID:
17979847
[PubMed - indexed for MEDLINE]
8.

Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy.

Thapa P, Zhang G, Xia C, Gelbard A, Overwijk WW, Liu C, Hwu P, Chang DZ, Courtney A, Sastry JK, Wang PG, Li C, Zhou D.

Vaccine. 2009 May 26;27(25-26):3484-8. doi: 10.1016/j.vaccine.2009.01.047. Epub 2009 Feb 5.

PMID:
19200815
[PubMed - indexed for MEDLINE]
9.

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.

Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, Ritter G, Schmidt R, Harris AL, Old L, Cerundolo V.

J Immunol. 2003 Nov 15;171(10):5140-7.

PMID:
14607913
[PubMed - indexed for MEDLINE]
Free Article
10.

Application of natural killer T cells in antitumor immunotherapy.

Hong C, Park SH.

Crit Rev Immunol. 2007;27(6):511-25. Review.

PMID:
18197797
[PubMed - indexed for MEDLINE]
11.

Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.

Fujii S.

Trends Immunol. 2008 May;29(5):242-9. doi: 10.1016/j.it.2008.02.002. Epub 2008 Mar 26. Review.

PMID:
18372215
[PubMed - indexed for MEDLINE]
12.

Potentiating antitumor immunity with αGC-loaded exosomes.

Gehrmann U, Hiltbrunner S, Näslund TI, Gabrielsson S.

Oncoimmunology. 2013 Oct 1;2(10):e26261. Epub 2013 Oct 10.

PMID:
24353911
[PubMed]
Free PMC Article
13.

IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.

Moreno M, Molling JW, von Mensdorff-Pouilly S, Verheijen RH, Hooijberg E, Kramer D, Reurs AW, van den Eertwegh AJ, von Blomberg BM, Scheper RJ, Bontkes HJ.

J Immunol. 2008 Aug 15;181(4):2446-54.

PMID:
18684935
[PubMed - indexed for MEDLINE]
Free Article
14.

Harnessing CD1d-restricted T cells toward antitumor immunity in humans.

Neparidze N, Dhodapkar MV.

Ann N Y Acad Sci. 2009 Sep;1174:61-7. doi: 10.1111/j.1749-6632.2009.04931.x.

PMID:
19769737
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy.

Wu TN, Lin KH, Chang YJ, Huang JR, Cheng JY, Yu AL, Wong CH.

Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17275-80. doi: 10.1073/pnas.1114255108. Epub 2011 Oct 10.

PMID:
21987790
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy.

Taniguchi M, Tashiro T, Dashtsoodol N, Hongo N, Watarai H.

Int Immunol. 2010 Jan;22(1):1-6. doi: 10.1093/intimm/dxp104. Epub 2009 Oct 25. Review.

PMID:
19858073
[PubMed - indexed for MEDLINE]
Free Article
17.

Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α.

Schneiders FL, de Bruin RC, Santegoets SJ, Bonneville M, Scotet E, Scheper RJ, Verheul HM, de Gruijl TD, van der Vliet HJ.

Clin Immunol. 2012 Feb;142(2):194-200. doi: 10.1016/j.clim.2011.10.006. Epub 2011 Nov 4.

PMID:
22122798
[PubMed - indexed for MEDLINE]
19.

Therapeutic effect of alpha-galactosylceramide-loaded dendritic cells genetically engineered to express SLC/CCL21 along with tumor antigen against peritoneally disseminated tumor cells.

Matsuyoshi H, Hirata S, Yoshitake Y, Motomura Y, Fukuma D, Kurisaki A, Nakatsura T, Nishimura Y, Senju S.

Cancer Sci. 2005 Dec;96(12):889-96.

PMID:
16367909
[PubMed - indexed for MEDLINE]
20.

Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity.

Nieda M, Okai M, Tazbirkova A, Lin H, Yamaura A, Ide K, Abraham R, Juji T, Macfarlane DJ, Nicol AJ.

Blood. 2004 Jan 15;103(2):383-9. Epub 2003 Sep 25.

PMID:
14512316
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk